Financial Results - Sotera Health Company announced preliminary revenue results for full-year 2025, which are within the guidance provided during the third quarter earnings release[8]. - The preliminary revenue results are subject to completion of year-end financial closing procedures and audit by the independent registered public accounting firm[8]. - The financial results are being disclosed under Item 2.02 and Item 7.01 of the SEC filing[10]. - The press release detailing the preliminary financial results was issued on January 12, 2026[6]. Company Information - The company is incorporated in Delaware and trades on The Nasdaq Stock Market under the symbol SHC[2]. - The address of the principal executive offices is 9100 South Hills Blvd, Suite 300, Broadview Heights, Ohio 44147[2]. - The company has not indicated any changes to its status as an emerging growth company[4]. Upcoming Events - The company will present a business update at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026[9]. Document Details - The report was signed by Jonathan M. Lyons, Senior Vice President and Chief Financial Officer[13]. - The press release is attached as Exhibit 99.1 in the SEC filing[11].
Sotera Health(SHC) - 2025 Q4 - Annual Results